Abstract
The effect of MHC class I gene transfection on the metastatic properties of B16BL6 melanoma cells was investigated. BL6-8 melanoma cells transfected with H-2K or H-2K, but not H-2D or H-2L, genes showed a dramatic reduction in their ability to generate experimental metastases in immunosuppressed CB6F1 mice. This observation suggested that some changes in the metastatic phenotype may have been induced in the H-2K- transfected melanoma cells. Analyses of adhesive and invasive properties of BL6-8 melanoma cells transfected with H-2 class I genes have been performed. We found that the loss of metastatic properties in the H-2K or H-2K gene-transfected melanoma cells was associated with reduced adherence to endothe-lial cells, laminin and collagen IV, decreased ability to form homotypic cell aggregates and with a complete loss of VLA-4 integrin expression. In addition, BL6-8 melanoma cells transfected with H-2K genes demon-strated reduced ability to invade Matrigel that paralleled up -regulation of TIMP-1 expression. Incubation of untransfected BL6-8 clone or B16F1 cells with 5-azacytidine similarly resulted in up-regulation of TIMP-1, suggesting that the changes in methylation of TIMP-1 gene could be responsible for TIMP-1 expression in the H-2K-transfected BL6-8 melanoma cells. Transfection of BL6-8 cells with the H-2D d /L d genes did not affect their adhesive and invasive properties. Previously we reported that reduction in the metastatic properties of the H-2K b transfected cells was associated with alterations in cell surface carbohydrates with appearance of a-galactosyl epitopes and reduction in cell surface sialylation. The present data indicate that, in addition to changes in cell surface carbohydrates, reduction in adhesive properties and up-regulation of TIMP-1 may be responsible for the observed loss of metastatic potential of BL6-8 cells transfected with the H-2K genes. © Rapid Science Ltd.
Similar content being viewed by others
References
Gorelik E, Peppoloni S, Overton R and Herberman R, 1985, Increase in H-2 antigen expression and immunogenicity of BL6 melanoma cells treated with N-methyl-N?-nitro-nitrosoguanidine. Cancer Res, 45, 5341-7.
Tanaka K, Gorelik E, Nozumi N and Jay G, 1988, Rejection of BL6 melanoma induced by the expression of a transfected MHC class I gene. Mol Cell Biol, 8, 1857-61.
Itoh T, Storkus W, Gorelik E and Lotze M, 1994, Partial purification of murine tumor-associated peptide epitopes common to histologically distinct tumors, melanoma and sarcoma, that are presented by H-2Kb molecules and recognized by CD8+ tumor infiltrating lymphocytes. J Immunol, 153, 1202-15.
Gorelik E, Jay G, Kwiatkowski B and Herberman R, 1990, Increased sensitivity to MHC-nonrestricted lysis of BL6 melanoma cells by transfection with class I H-2Kb gene. J Immunol, 145, 1621-32.
Kim M, Herberman R and Gorelik E, 1993, Increased sensitivity to TNF-mediated cytotoxicity of BL6 melanoma cells after H-2Kb gene transfection. J Immunol, 151, 3467-77.
Kim M, Duty L, Herberman R and Gorelik E, 1994, Divergent effects of H-2K and H-2D genes on sensitivity of BL6 melanoma cells to NK cells or TNF-mediated cytotoxicity. Cell Immunol, 155, 358-71.
Gorelik E, Kim M, Duty, Henion T and Galili U, 1993, Control of metastatic properties of BL6 melanoma cells by H-2Kb gene: immunological and nonimmunological mechanisms. Clin Exp Metastasis, 11, 439-52.
Gorelik E, Jay G, Kim M, Hearing V, DeLeo A and McCoy P, 1991, Effects of H-2Kb gene on expression of melanoma-associated antigen and lectin-binding sites on BL6 melanoma cells. Cancer Res, 51, 5212-18.
Leong S, Muller J, Yetter R, Gorelik E, Takami T and Hearing V, 1988, Expression and modulation of a retrovirus-associated antigen by murine melanoma cells. Cancer Res, 48, 4954-8.
Li M, Muller J, Xu F, Hearing V and Gorelik E, 1996, Inhibition of melanoma-associated antigen expression and ecotropic retrovirus production in BL6 melanoma cells transfected with MHC class I genes. Cancer Res, 56, 4464-74.
Muller J, Khan A, Li M, Rao V, Hearing V and Gorelik E, 1996, Phenotypic alterations and loss of melanoma-specific endogenous C-type retrovirus production in BL6 melanoma cells transfected with the H-2Kb gene. Melanoma Res, 6, 101-11.
Li M, Muller J, Rao V, Hearing V, Lueders K and Gorelik E, 1996, Loss of intracisternal A-type retroviral particles in BL6 melanoma cells transfected with MHC class I genes. J General Virol, 77, 2757-65.
Prezioso J, Hearing V, Muller J, Urabe K, Wang N and Gorelik E, 1995, Impairment of the melanogenic pathway in BL6 melanoma cells transfected with class I H-2 genes. Melanoma Res, 5, 15-36.
Gorelik E, Duty L, Anaraki F and Galili U, 1995, Alterations of cell surface carbohydrates and inhibition of metastatic properties of murine melanomas by α1,3 galactosyltransferase gene transfection. Cancer Res, 55, 4168-73.
Auerbach R, Alby L, Grieves J et al. 1982, Monoclonal antibody against angiotensin-converting enzyme: its use as a marker for murine, bovine and human endothelial cells. Proc Natl Acad Sci USA, 86, 8227-31.
Giovanni C, Palmieri G, Nicoletti, G, et al. 1991, Immunological and non-immunological influence of H-2Kb gene transfection on the metastatic ability of B16 melanoma cells. Int J Cancer, 48, 270-6.
Sambrook J, Fritsch E and Maiatiatis T, 1989, Molecular Cloning: a laboratory manual. New York: Cold Spring Harbor Laboratory.
Sun Y, Hegamyer G, Kim H, Sithanadandam K, Li H, Watts R and Colburn N, 1995, Molecular cloning of mouse tissue inhibitor of metalloproteinases-3 and its promoter. J Cell Biol, 270, 19312-19.
Rubio M, Nueda A, Vara A and Lopez A-C, 1992, A single mRNA encodes the ?150 and ?80/70 forms of the a subunit of VLA-4. Eur J Immunol, 22, 1099-102.
Edwards D, Rocheleau H, Sharma R, et al. 1992, Involvement of AP1 and PEA3 binding sites in the regulation of murine tissue inhibitor of metalloproteinases-1 (TIMP-1) transcription. Biochem Biophys Acta, 1171, 41-55.
Qian F, Vaux D and Weissman I, 1994, Expression of the integrin α4β1 on melanoma cells can inhibit the invasive stage of metastasis formation. Cell, 77, 335-47.
Heussen C and Dowdle E, 1980, Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Analyt Biochem, 102, 196-202.
Kohn E and Liotta L, 1995, Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res, 55, 1856-62.
Matrisian L, 1990, Metalloproteinases and their inhibitors in matrix remodeling. Trends Gen, 6, 121-5.
Hynes R, 1992, Integrins: versatility, modulation and signaling in cell adhesion. Cell, 69, 11-15.
Heino J, 1996, Biology of tumor cell invasion: interplay of cell adhesion and matrix degradation. Int J Cancer, 65, 717-22.
Altevogt P, Hubbe M, Ruppert M, et al. 1995, The α4 integrin chain is a ligand for α4β7 and α4β1. J Exp Med, 182, 34-42.
Khokha R and Denhardt D, 1989, Matrix metalloproteinases and tissue inhibitor of metalloproteinases: a review of their role in tumorigenesis and tissue invasion. Invasion Metastasis, 9, 391-405.
Khokha R, Waterhouse P, Yagel S, Lala P, et al. 1989, Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. Science, 243, 947-50.
Khokha R, Zimmer M, Graham G, Lala P and Warehouse P, 1992, Suppression of invasion by inducible expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in B16-F10 melanoma cells. J Natl Cancer Inst, 84, 1017-22.
Koop S, Khokha R, Schmidt, E, et al. 1994, Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth. Cancer Res, 54, 4791-7.
Laird P and Jaenisch R, 1994, DNA methylation and cancer. Human Mol Genet, 3, 1487-95.
Jones P, 1996, DNA methylation errors and cancer. Cancer Res, 56, 2463-7.
Calarini L, Marozzi A, Byers H, et al. 1992, Expression of a transfected H-2Kb gene in B16 melanoma cells correlates with suppression of liver metastases in triple immunodeficient mice. Cancer Res, 52, 4036-41.
Lauri D, Giovanni C, Biondelli T, et al. 1993, Decreased adhesion to endothelial cells and matrix proteins of H-2Kb gene transfected tumour cells. Br J Cancer, 68, 862-7.
De Giovanni C, Nicoletti G, Sensi M, Santoni A, et al. 1994, H-2Kb and H-2Db gene transfections in B16 melanoma differently affect non-immunological properties relevant to the metastatic process. Involvement of integrin molecules. J Int Cancer, 59, 269-74.
Pargador A, Feldman M and Eisenbach L, 1989, H-2Kb transfection of B16 melanoma cells results in reduced tumorigenicity and metastatic competence. J Immunogenet, 16, 291-303.
Okahara H, Yagita H, Miyake K and Okumura K, 1994, Involvement of VLA-4 and VCAM-1 in TNF??enhancement of experimental metastasis. Cancer Res, 54 3233-6.
Garofalo A, Chirivi R, Foglieni C, et al. 1995, Involvement of the VLA-4 integrin on melanoma in IL-1-augmented experimental metastases. Cancer Res, 55, 414-19.
Vardi I, Gopas J, Rager-Zisman B, Hammerling G, Segal S and Aboud M, 1992, Differential expression of the H-2Dk MHC class I antigen and tissue inhibitor of metalloproteinases in metastatic and nonmetastatic T-10 fibrosarcoma cells. Invasion Metastasis, 12, 301-8.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Xu, F., Carlos, T., Li, M. et al. Inhibition of VLA-4 and up-regulation of TIMP-1 expression in B16BL6 melanoma cells transfected with MHC class I genes. Clin Exp Metastasis 16, 358–370 (1998). https://doi.org/10.1023/A:1006569631330
Issue Date:
DOI: https://doi.org/10.1023/A:1006569631330